Malta vs Sweden: Cause of death, by non-communicable diseases, ages 60+, male
Malta
84.1%
in 2021
Sweden
83.8%
in 2021
Malta rank
18th
Sweden rank
20th
Cause of death, by non-communicable diseases, ages 60+, male over time
- Malta
- Sweden
How they compare
Malta currently reports 84.1% against 83.8% in Sweden, a difference of 0.3%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Sweden ahead.
Malta ranks 18th and Sweden ranks 20th of 185 countries.
Across the 3 decades both report, Malta averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Malta | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.0% | 91.5% | 1.5% | Sweden |
| 2010s | 91.8% | 90.5% | 1.4% | Malta |
| 2020s | 83.8% | 82.2% | 1.7% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, Malta or Sweden?
- Malta, at 84.1% against 83.8% in Sweden as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between Malta and Sweden?
- 0.3%, with Malta ahead.
- How many years of comparable data are there for Malta and Sweden?
- 6 years are reported by both, from 2000 to 2021.
- How do Malta and Sweden rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- Malta ranks 18th and Sweden ranks 20th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.